Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep 5:2:180.
doi: 10.3389/fmicb.2011.00180. eCollection 2011.

Gut microbiota, immunity, and disease: a complex relationship

Affiliations

Gut microbiota, immunity, and disease: a complex relationship

Michele M Kosiewicz et al. Front Microbiol. .

Abstract

Our immune system has evolved to recognize and eradicate pathogenic microbes. However, we have a symbiotic relationship with multiple species of bacteria that occupy the gut and comprise the natural commensal flora or microbiota. The microbiota is critically important for the breakdown of nutrients, and also assists in preventing colonization by potentially pathogenic bacteria. In addition, the gut commensal bacteria appear to be critical for the development of an optimally functioning immune system. Various studies have shown that individual species of the microbiota can induce very different types of immune cells (e.g., Th17 cells, Foxp3(+) regulatory T cells) and responses, suggesting that the composition of the microbiota can have an important influence on the immune response. Although the microbiota resides in the gut, it appears to have a significant impact on the systemic immune response. Indeed, specific gut commensal bacteria have been shown to affect disease development in organs other than the gut, and depending on the species, have been found to have a wide range of effects on diseases from induction and exacerbation to inhibition and protection. In this review, we will focus on the role that the gut microbiota plays in the development and progression of inflammatory/autoimmune disease, and we will also touch upon its role in allergy and cancer.

Keywords: Th17; Treg; allergy; autoimmunity; cancer; commensal bacteria; microbiota; probiotics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Impact of the composition of the flora on the immune response and disease development. Dysbiosis can arise from either (1) a reduction in Treg-inducing bacteria (e.g., Bifidobacteria or Bacteroides) that results in decreased Tregs, but unchanged levels of Teff cells; or (2) an enrichment in pro-inflammatory bacteria (e.g., SFB) that results in increased Teff cells, but unchanged levels of Tregs. In both cases, the Treg:Teff cell balance is biased toward the Teff cells, and the outcome of this imbalance can be development of disease in genetically susceptible individuals.

Similar articles

Cited by

References

    1. Alard P., Parnell S. A., Manirarora J. N., Kosiewicz M. M. (2009). Probiotics control lupus progression via induction of regulatory cells and IL-10 production. J. Immunol. 182, 50.30
    1. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D. R., Fernandes G. R., Tap J., Bruls T., Batto J. M., Bertalan M., Borruel N., Casellas F., Fernandez L., Gautier L., Hansen T., Hattori M., Hayashi T., Kleerebezem M., Kurokawa K., Leclerc M., Levenez F., Manichanh C., Nielsen H. B., Nielsen T., Pons N., Poulain J., Qin J., Sicheritz-Ponten T., Tims S., Torrents D., Ugarte E., Zoetendal E. G., Wang J., Guarner F., Pedersen O., De Vos W. M., Brunak S., Dore J., Consortium M., Weissenbach J., Ehrlich S. D., Bork P., Antolin M., Artiguenave F., Blottiere H. M., Almeida M., Brechot C., Cara C., Chervaux C., Cultrone A., Delorme C., Denariaz G., Dervyn R., Foerstner K. U., Friss C., Van De Guchte M., Guedon E., Haimet F., Huber W., Van Hylckama-Vlieg J., Jamet A., Juste C., Kaci G., Knol J., Lakhdari O., Layec S., Le Roux K., Maguin E., Merieux A., Melo Minardi R., M’Rini C., Muller J., Oozeer R., Parkhill J., Renault P., Rescigno M., Sanchez N., Sunagawa S., Torrejon A., Turner K., Vandemeulebrouck G., Varela E., Winogradsky Y., Zeller G. (2011). Enterotypes of the human gut microbiome. Nature 43, 174–18010.1038/nature09944 - DOI - PMC - PubMed
    1. Asher M. I. (1998). Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur. Respir. J. 12, 315–335 - PubMed
    1. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., Cheng G., Yamasaki S., Saito T., Ohba Y., Taniguchi T., Takeda K., Hori S., Ivanov Ii., Umesaki Y., Itoh K., Honda K. (2011). Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337–34110.1126/science.1198469 - DOI - PMC - PubMed
    1. Baharav E., Mor F., Halpern M., Weinberger A. (2004). Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J. Nutr. 134, 1964–1969 - PubMed

LinkOut - more resources